Skip to main content
Erweiterte Suche
Anmelden
nach oben
Deutsche Dermatologie
Erschienen in:

01.03.2025 | Psoriasis vulgaris | Fortbildung

Psoriasistherapie

Besonderheiten bei Frauen beachten

verfasst von: Dr. med. Nina Magnolo, Paloma Seidel

Erschienen in: Deutsche Dermatologie | Ausgabe 3/2025

Einloggen, um Zugang zu erhalten

Auszug

Die Psoriasis tritt bei Frauen und Männern ungefähr gleich häufig auf. Allerdings gibt es geschlechtsspezifische Unterschiede und Herausforderungen hinsichtlich Krankheitsverlauf, Patientenbedürfnissen und Therapiemanagement. …
Literatur
1.
Griffiths CEM et al. Psoriasis. Lancet. 2021;397:1301-15
2.
Sondermann W et al. Psoriasis, cardiovascular risk factors and metabolic disorders: sex-specific findings of a population-based study. J Eur Acad Dermatol Venereol. 2020;34:779-86
3.
Bucur Ș et al. Oversight and Management of Women with Psoriasis in Childbearing Age. Medicina (Kaunas). Medicina 2022;58:789
4.
Napolitano M et al. Sex- and gender-associated clinical and psychosocial characteristics of patients with psoriasis. Clin Exp Dermatol. 2020;45:705-11
5.
Brunasso AMG et al. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study. Br J Dermatol. 2013;168:1243-51
6.
Hägg D et al. Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients. Am J Clin Dermatol. 2017;18:583-90
7.
Murer C et al. Gender differences in psoriasis: a Swiss online psoriasis survey. Arch Dermatol Res. 2021;313:89-94
8.
Maul J-T et al. Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry study. Br J Dermatol. 2021;185:1160-8
9.
Tarannum S et al. Sex- and gender-related differences in psoriatic arthritis. Nat Rev Rheumatol. 2022;18:513-26
10.
Augustin M et al. Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol. 2010;163:580-5
11.
Da Silva N et al. Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care. PLoS One. 2020;15:e0235091
12.
Meeuwis KAP et al. Patients‘ experience of psoriasis in the genital area. Dermatology. 2012;224:271-6
13.
Gonzalez-Cantero A et al. Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists. Int J Womens Dermatol. 2023;9:e112
14.
Adesanya EI et al. Factors associated with depression, anxiety and severe mental illness among adults with atopic eczema or psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2023;188:460-70
15.
Lim DS et al. Psychological Profile of Patients with Psoriasis. Ann Acad Med Singap. 2018;47:516-22
16.
Jankowiak B et al. Stigmatization among Patients with Plaque Psoriasis. J Clin Med. 2023;12:6425
17.
Maul J-T et al. Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice. J Eur Acad Dermatol Venereol. 2019;33:700-8
18.
Nyberg F et al. „The Laundry Bag Project“ - unequal distribution of dermatological healthcare resources for male and female psoriatic patients in Sweden. Int J Dermatol. 2008;47:144-9
19.
Hernández-Fernández CP et al. Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort. Acta Derm Venereol. 2021;101:adv00354
20.
Verardi F et al. Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT). J Eur Acad Dermatol Venereol. 2024;38:719-31
21.
Di Cesare A et al. Risk of acute infections in psoriatic patients during biologic therapies is linked to gender. J Eur Acad Dermatol Venereol. 2019;33:e362-4
22.
Augustin M et al. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162:633-6
23.
Mahé E. Childhood psoriasis. Eur J Dermatol. 2016;26:537-48
24.
Iskandar IYK et al. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol. 2021;184:243-58
25.
S2k-Leitlinie „Therapie der Psoriasis bei Kindern und Jugendlichen“. 2021. AWMF-Reg.-Nr. 013-094
26.
Ceovic R et al. Psoriasis: female skin changes in various hormonal stages throughout life - puberty, pregnancy, and menopause. Biomed Res Int. 2013;2013:571912
27.
Wu S et al. Hormonal Factors and Risk of Psoriasis in Women: A Cohort Study. Acta Derm Venereol. 2016;96:927-31
28.
Bello GD et al. Variations of symptoms of atopic dermatitis and psoriasis in relation to menstrual cycle. J Am Acad Dermatol. 2022;87:892-5
29.
Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008;8:737-44
30.
Guillet C et al. The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis. Int J Womens Dermatol. 2022;8:e010
31.
Chen T-C et al. Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UK. JAMA Dermatol. 2023;159:736-44
32.
Gonzalez-Cantero A et al. Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50 % reduction in age-adjusted fertility rate when compared with the general population. Br J Dermatol. 2019;181:1085-7
33.
Aydogan Mathyk B et al. Evaluation of ovarian reserve in women with psoriasis. Gynecol Endocrinol. 2019;35:608-11
34.
Lambe M et al. Reproductive patterns and maternal and pregnancy outcomes in women with psoriasis - A population-based study. J Am Acad Dermatol. 2020;82:1109-16
35.
Bröms G et al. Effect of Maternal Psoriasis on Pregnancy and Birth Outcomes: A Population-based Cohort Study from Denmark and Sweden. Acta Derm Venereol. 2018;98:728-34
36.
Maccari F et al. Contraception, Sexuality and Pregnancy in Women with Psoriasis: Real-Life Experience of 235 Women. Clin Cosmet Investig Dermatol. 2020;13:817-23
37.
Murase JE et al. Hormonal effect on psoriasis in pregnancy and post partum. Arch Dermatol. 2005;141:601-6
38.
Maccari F et al. Crossed looks on the dermatologist‘s position and the patient‘s preoccupations as to psoriasis and pregnancy: preliminary results of the PREGNAN-PSO study. J Eur Acad Dermatol Venereol. 2019;33:880-5
39.
McMullan P et al. Safety of dermatologic medications in pregnancy and lactation: An update - Part I: Pregnancy. J Am Acad Dermatol. 2024;91:619-48
40.
Yaghi M et al. Safety of dermatologic medications in pregnancy and lactation: An update - Part II: Lactation. J Am Acad Dermatol. 2024;91:651-68
41.
Balakirski G et al. Therapy of psoriasis during pregnancy and breast-feeding. J Dtsch Dermatol Ges. 2022;20:653-83
42.
Zhang M et al. Folate and phototherapy: What should we inform our patients? J Am Acad Dermatol. 2017;77:958-64
43.
Mariette X et al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis. 2018;77:228-33
44.
Clowse ME et al. Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study. Ann Rheum Dis. 2017;76:1890-6
45.
Nast A et al. Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm - Teil 1: Therapieziele und Therapieempfehlungen. J Dtsch Dermatol Ges. 2021;19:934-51
46.
Sousa P et al. Navigating Reproductive Care in Patients With Inflammatory Bowel Disease: A Comprehensive Review. J Crohns Colitis. 2024;18(Suppl 2):ii16-30
47.
Götestam Skorpen C et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795-810
Metadaten
Titel
Psoriasistherapie
Besonderheiten bei Frauen beachten
verfasst von
Dr. med. Nina Magnolo
Paloma Seidel
Publikationsdatum
01.03.2025
Verlag
Springer Medizin
Erschienen in
Deutsche Dermatologie / Ausgabe 3/2025
Print ISSN: 2731-7692
Elektronische ISSN: 2731-7706
DOI
https://doi.org/10.1007/s15011-025-6842-3

Weitere Artikel der Ausgabe 3/2025

EU-Strategie für Arbeitskräfte im Gesundheitswesen

Nachrichten

Raumpatrouille 2025

  • Newsmix

Fristverlängerung bei Wundbehandlung

Recht

Candida auris: Wie mit dem expansiven Hefepilz umzugehen ist

Passend zum Thema

ANZEIGE

Lebensqualität bei atopischer Dermatitis: Interview mit Prof. Diamant Thaçi

Die atopische Dermatitis (AD) greift tief in den Alltag der Betroffenen ein – besonders Juckreiz und schlechter Schlaf mindern die Lebensqualität spürbar. Wie stark der Schweregrad von AD das Wohlbefinden prägt und wie die Lebensqualität langfristig gesteigert werden kann, erläutert Prof. Diamant Thaçi im Interview.

ANZEIGE

Atopische Dermatitis schläft nicht: Interview mit Dr. Caroline Mann

Erholsamer Schlaf ist entscheidend für Wohlbefinden, Leistungsfähigkeit und ein starkes Immunsystem. Bei atopischer Dermatitis kann nächtlicher Juckreiz Schlafstörungen verursachen und die Lebensqualität erheblich mindern. In einem Interview präsentiert Dr. Caroline Mann spannende Studien, die den engen Zusammenhang zwischen Schlafqualität und AD verdeutlichen.

ANZEIGE

Neueste Erkenntnisse zum Hautmikrobiom: vier Experten im Gespräch

  • Content Hub

Die Experten Prof. Luger (Münster), Prof. Zuberbier (Berlin), Prof. Thaçi (Lübeck) und PD Dr. Jansen (Essen) erörtern im von La Roche-Posay unterstützen Expertenworkshop die Bedeutung des Mikrobioms für verschiedene Hautkrankheiten wie atopische Dermatitis, Akne oder Rosazea.

La Roche-Posay
Bildnachweise